PortfoliosLab logoPortfoliosLab logo
SOL vs. HIVE
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

SOL vs. HIVE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ReneSola Ltd (SOL) and HIVE Blockchain Technologies Ltd (HIVE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

SOL vs. HIVE - Yearly Performance Comparison


Fundamentals

Market Cap

SOL:

$99.60M

HIVE:

$454.17M

EPS

SOL:

-$0.10

HIVE:

-$0.33

PS Ratio

SOL:

1.40

HIVE:

1.63

PB Ratio

SOL:

0.32

HIVE:

0.81

Total Revenue (TTM)

SOL:

$71.23M

HIVE:

$257.14M

Gross Profit (TTM)

SOL:

$24.18M

HIVE:

$58.57M

EBITDA (TTM)

SOL:

-$20.64M

HIVE:

$87.81M

Returns By Period


SOL

1D
0.00%
1M
0.00%
YTD
6M
1Y
3Y*
5Y*
10Y*

HIVE

1D
8.57%
1M
-11.21%
YTD
-26.36%
6M
-52.85%
1Y
31.03%
3Y*
-16.72%
5Y*
-37.45%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SOL vs. HIVE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SOL

HIVE
HIVE Risk / Return Rank: 5555
Overall Rank
HIVE Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
HIVE Sortino Ratio Rank: 6161
Sortino Ratio Rank
HIVE Omega Ratio Rank: 5757
Omega Ratio Rank
HIVE Calmar Ratio Rank: 5151
Calmar Ratio Rank
HIVE Martin Ratio Rank: 5050
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SOL vs. HIVE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ReneSola Ltd (SOL) and HIVE Blockchain Technologies Ltd (HIVE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

SOL vs. HIVE - Sharpe Ratio Comparison


Loading graphics...

Sharpe Ratios by Period


SOLHIVEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.36

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.40

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.19

Dividends

SOL vs. HIVE - Dividend Comparison

Neither SOL nor HIVE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SOL vs. HIVE - Drawdown Comparison

The maximum SOL drawdown since its inception was 0.00%, smaller than the maximum HIVE drawdown of -97.73%. Use the drawdown chart below to compare losses from any high point for SOL and HIVE.


Loading graphics...

Drawdown Indicators


SOLHIVEDifference

Max Drawdown

Largest peak-to-trough decline

0.00%

-97.73%

+97.73%

Max Drawdown (1Y)

Largest decline over 1 year

-74.86%

Max Drawdown (5Y)

Largest decline over 5 years

-94.61%

Current Drawdown

Current decline from peak

0.00%

-92.92%

+92.92%

Average Drawdown

Average peak-to-trough decline

0.00%

-78.35%

+78.35%

Ulcer Index

Depth and duration of drawdowns from previous peaks

39.08%

Volatility

SOL vs. HIVE - Volatility Comparison


Loading graphics...

Volatility by Period


SOLHIVEDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.67%

Volatility (6M)

Calculated over the trailing 6-month period

66.86%

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

87.64%

-87.64%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

93.05%

-93.05%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

109.03%

-109.03%

Financials

SOL vs. HIVE - Financials Comparison

This section allows you to compare key financial metrics between ReneSola Ltd and HIVE Blockchain Technologies Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
15.64M
93.11M
(SOL) Total Revenue
(HIVE) Total Revenue
Values in USD except per share items

SOL vs. HIVE - Profitability Comparison

The chart below illustrates the profitability comparison between ReneSola Ltd and HIVE Blockchain Technologies Ltd over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
60.8%
34.5%
Portfolio components
SOL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, ReneSola Ltd reported a gross profit of 9.52M and revenue of 15.64M. Therefore, the gross margin over that period was 60.8%.

HIVE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, HIVE Blockchain Technologies Ltd reported a gross profit of 32.14M and revenue of 93.11M. Therefore, the gross margin over that period was 34.5%.

SOL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, ReneSola Ltd reported an operating income of 6.82M and revenue of 15.64M, resulting in an operating margin of 43.6%.

HIVE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, HIVE Blockchain Technologies Ltd reported an operating income of 16.70M and revenue of 93.11M, resulting in an operating margin of 17.9%.

SOL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, ReneSola Ltd reported a net income of 3.47M and revenue of 15.64M, resulting in a net margin of 22.2%.

HIVE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, HIVE Blockchain Technologies Ltd reported a net income of -91.33M and revenue of 93.11M, resulting in a net margin of -98.1%.